BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10103840)

  • 21. Quality assurance for the JCAHO standards.
    Chase PA
    Am J Hosp Pharm; 1991 Jul; 48(7):1550-2. PubMed ID: 1882891
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of JCAH standards in negligence suits.
    Fink JL
    Am J Hosp Pharm; 1981 Jun; 38(6):892-6. PubMed ID: 6941698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nursing unit inspections.
    Hoffmann RP
    Hosp Pharm; 1989 Nov; 24(11):953-4. PubMed ID: 10296148
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmaceutical care plans. What does the Joint Commission require regarding pharmacy care plans?
    Rich DS
    Hosp Pharm; 1994 Feb; 29(2):176-8, 181. PubMed ID: 10132152
    [No Abstract]   [Full Text] [Related]  

  • 25. Joint Commission survey questions and answers.
    Arnold S; Aziz G; Betcher J; Williams D; Threlkeld K; Stubblefield T
    Pharm Pract Manag Q; 1999 Apr; 19(1):63-9. PubMed ID: 10351610
    [No Abstract]   [Full Text] [Related]  

  • 26. The new survey process and input into standards development.
    Rich DS
    Hosp Pharm; 1994 Mar; 29(3):289-90. PubMed ID: 10132700
    [No Abstract]   [Full Text] [Related]  

  • 27. 1988 Joint Commission survey in a community hospital.
    Guharoy S; Barajas M; McGalliard J; Aguer T
    Hosp Pharm; 1989 Apr; 24(4):287-9. PubMed ID: 10293284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are you ready for JCAHO's medication standards?
    Hosp Peer Rev; 2005 Feb; 30(2):22-4. PubMed ID: 15717624
    [No Abstract]   [Full Text] [Related]  

  • 29. Help pharmacists meet new medication standards.
    Hosp Peer Rev; 2004 Mar; 29(3):33-4, 39. PubMed ID: 15015432
    [No Abstract]   [Full Text] [Related]  

  • 30. JCAHO's pharmaceutical care plan requirements.
    Rich DS
    Hosp Pharm; 1995 Apr; 30(4):315-9. PubMed ID: 10141874
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse drug reaction reporting--proposal to implement a revised system.
    Linkewich JA
    Hosp Pharm; 1989 Feb; 24(2):122-4. PubMed ID: 10292192
    [No Abstract]   [Full Text] [Related]  

  • 32. The Joint Commission's agenda for change.
    Ente BH
    Curr Concepts Hosp Pharm Manage; 1989; 11(2):6-14. PubMed ID: 10293152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Planning for a JCAH survey.
    Crane VS; Louviere ML
    Am J Hosp Pharm; 1982 Oct; 39(10):1665-71. PubMed ID: 6959531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unannounced surveys.
    Rich DS
    Hosp Pharm; 1993 Aug; 28(8):801, 807. PubMed ID: 10127577
    [No Abstract]   [Full Text] [Related]  

  • 35. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 36. Codes + standards. Pharmacy facts. Architectural and environmental changes required for USP 797.
    Bernstein WN
    Health Facil Manage; 2005 Jul; 18(7):39-40. PubMed ID: 16130375
    [No Abstract]   [Full Text] [Related]  

  • 37. The agenda for change in a changing profession.
    Enright SM
    Curr Concepts Hosp Pharm Manage; 1989; 11(2):15-7. PubMed ID: 10293150
    [No Abstract]   [Full Text] [Related]  

  • 38. JCAHO (Joint Commission on Accreditation of Healthcare Organizations) explains standards.
    Cerne F
    Hospitals; 1988 Jan; 62(1):72. PubMed ID: 3422068
    [No Abstract]   [Full Text] [Related]  

  • 39. Working toward uniformity in evaluation of ADR-reporting programs.
    Woodson HA
    Am J Hosp Pharm; 1991 Jul; 48(7):1428. PubMed ID: 1882866
    [No Abstract]   [Full Text] [Related]  

  • 40. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.